Convergys Corp. (CVG) Tops Q2 EPS by 2c; Raises Guidance and Stock Buyback
Tweet
Share
E-mailGet Alerts CVG Hot Sheet
Price: $24.41 --0%
Financial Fact:
Continuing operations: 0.39
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Continuing operations: 0.39
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Convergys Corp. (NYSE: CVG) reported Q2 EPS of $0.19, $0.02 better than the analyst estimate of $0.17. Revenue for the quarter came in at $491 million versus the consensus estimate of $483.85 million.
Convergys Corp. sees FY2012 EPS of $0.80-$0.85, versus prior guidance of $0.75-$0.80 and the consensus of $0.79.
The company also announced that the Board of Directors approved increasing the authorization for share repurchases to $250 million in the aggregate.
For earnings history and earnings-related data on Convergys Corp. (CVG) click here.
Convergys Corp. sees FY2012 EPS of $0.80-$0.85, versus prior guidance of $0.75-$0.80 and the consensus of $0.79.
The company also announced that the Board of Directors approved increasing the authorization for share repurchases to $250 million in the aggregate.
For earnings history and earnings-related data on Convergys Corp. (CVG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
Earnings, Guidance, Stock BuybacksRelated Entities
Stock Buyback, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
